Automated laser retraction for targeted glioblastoma coverage during laser interstitial thermal therapy

激光间质热疗过程中用于靶向覆盖胶质母细胞瘤的自动激光回缩

阅读:1

Abstract

BACKGROUND: Current magnetic resonance guided laser interstitial thermal therapy (MRgLITT) requires physician input to incrementally retract the laser probe during glioblastoma (GBM) treatment, to achieve maximum safe lesion coverage (LC). OBJECTIVE: Through this computational study, we propose an automated MRgLITT system based on temperature and thermal damage feedback to enable precise laser probe positioning and achieve the target LC during GBM treatment. METHODS: Our goal was to design a cascaded proportional-integral-derivative (PID) controller with a fuzzy logic controller to achieve thermal damage, Ω ≥ 0.99 within 90% of the target tumor volume. Two modelling approaches were explored for PID control system to maintain the tumor boundary temperature at: (i) constant optical properties and (ii) variable optical properties. A fuzzy-logic controller was used to incrementally retract the laser probe once the thermal damage at the corresponding boundary setpoint reached the target (Ω = 0.99). The PID and fuzzy logic controller was designed in the system dynamic modeling software, MATLAB Simulink, and bioheat transfer physics was modelled using the finite element analysis (FEA) software, COMSOL Multiphysics. FEA simulations were performed on a de-identified patient voxel model consisting of domains such as the skull, CSF, brain and tumor. The laser probe was modeled as a cylinder with a diameter of 1.65 mm and tip length of 5 mm. The temperature and thermal damage measuring probes were modeled to represent the thermal imaging planes from clinically approved LITT systems. RESULTS: The results indicated that the automated control framework maintained the tumor boundary temperature at 60°C. The designed automated control framework did not achieve the target LC but increased the LC by ∼25% with reduction in treatment time. CONCLUSION: The results of this computational study indicate that the designed automated MRgLITT approach has potential to improve the LC, reduce treatment time and operator specific variability. Future efforts will focus on developing and validating the proposed approach.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。